tiprankstipranks
Trending News
More News >
Scopus BioPharma (SCPS)
OTHER OTC:SCPS
US Market

Scopus BioPharma (SCPS) Income Statement

Compare
67 Followers

Scopus BioPharma Income Statement

Last quarter (Q2 2023), Scopus BioPharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Scopus BioPharma's net income was $-2.62M. See Scopus BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 11.71M$ 27.63M$ 10.16M$ 2.69M$ 685.96K
Depreciation and Amortization
$ 1.73K$ 1.50K$ 1.44K$ 664.00$ 161.14K
EBITDA
$ -11.71M$ -27.63M$ -10.15M$ -2.69M$ -685.96K
Operating Income
$ -11.71M$ -27.63M$ -10.16M$ -2.69M$ -685.96K
Other Income/Expenses
$ 0.00$ 681.21K$ -706.45K$ 0.00$ 0.00
Pretax Income
$ -11.71M$ -26.95M$ -10.86M$ -2.69M$ -685.96K
Net Income
$ -11.61M$ -27.73M$ -11.57M$ -2.69M$ -685.96K
Per Share Metrics
Basic EPS
$ -0.55$ -1.61$ -0.87$ -0.18$ -0.05
Diluted EPS
$ -0.55$ -1.61$ -0.87$ -0.18$ -0.05
Weighted Average Shares Outstanding
21.09M 17.25M 13.36M 14.98M 14.98M
Weighted Average Shares Outstanding (Diluted)
21.09M 17.25M 13.36M 14.98M 14.98M
Currency in USD

Scopus BioPharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis